Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIAsp vs insulin aspart with CSII in adults with type 1 diabetes
2013-002233-37Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of human insulin and insulin aspart in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Novo Nordisk. Primary endpoint: Number of microscopically confirmed episodes of infusion set occlusions. Started Sep 2013; status: completed.
02
Drugs
human insulininsulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2013-002233-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002233-37.